LifeNet Health’s $85 Million Acquisition of Bioventus’ Wound Business

Reed Smith advised Bioventus on the sale.Bioventus Inc. (Nasdaq: BVS) announced that it signed a definitive agreement to sell its Wound business, including the skin substitutes…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now